SHP-1 is a potent negative regulator of growth-factor signalling but the expression of SHP-1 and its contribution to vascular restenosis in animal models of obesity and type 2 diabetes have not been investigated. This evidence concerns the gene PTPN6 and obesity due to melanocortin 4 receptor deficiency.